Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pcl.2013.08.009 http://scihub22266oqcxt.onion/10.1016/j.pcl.2013.08.009 C5384653!5384653!24237984     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Clin+North+Am 2013 ; 60 (6): 1489-511 Nephropedia Template TP {{tp|p=24237984|t=2013. Diagnosis and Management of Autoimmune Cytopenias in Childhood |pdf=|usr=}}{{24237984}} gab.com Text Diagnosis and Management of Autoimmune Cytopenias in Childhood JO: Pediatr Clin North Am http://www.kidney.de/pget.php?&tw=1&pmid=24237984 #FOAvip The diagnosis and management of children with autoimmune cytopenias can be challenging, as this diagnostic category encompasses a number of heterogeneous but closely related conditions. Children can present with immune-mediated destruction of a single cell lineage or multiple cell lineages, including platelets (immune thrombocytopenia, ITP), erythrocytes (autoimmune hemolytic anemia), and neutrophils (autoimmune neutropenia). Immune-mediated destruction can be primary or secondary to a co-morbid immunodeficiency, malignancy, rheumatologic condition, or lymphoproliferative disorder. Despite the heterogeneity, treatment options are similar and generally consist of non-specific immune suppression or modulation. Fortunately, this non-specific approach is changing as recent insights into disease biology have led to targeted therapies for certain patients, including the use of thrombopoietin mimetics in ITP and sirolimus for cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Twit Text FOAVip Diagnosis and Management of Autoimmune Cytopenias in Childhood ????Pediatr Clin North Am http://www.kidney.de/pget.php?&tw=1&pmid=24237984 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24237984 #FOAvip English Wikipedia <ref>{{Cite pmid|24237984}}</ref> Diagnosis and Management of Autoimmune Cytopenias in Childhood #MMPMID24237984 Teachey DT; Lambert MP Pediatr Clin North Am 2013[Dec]; 60 (6): 1489-511 PMID24237984show ga The diagnosis and management of children with autoimmune cytopenias can be challenging, as this diagnostic category encompasses a number of heterogeneous but closely related conditions. Children can present with immune-mediated destruction of a single cell lineage or multiple cell lineages, including platelets (immune thrombocytopenia, ITP), erythrocytes (autoimmune hemolytic anemia), and neutrophils (autoimmune neutropenia). Immune-mediated destruction can be primary or secondary to a co-morbid immunodeficiency, malignancy, rheumatologic condition, or lymphoproliferative disorder. Despite the heterogeneity, treatment options are similar and generally consist of non-specific immune suppression or modulation. Fortunately, this non-specific approach is changing as recent insights into disease biology have led to targeted therapies for certain patients, including the use of thrombopoietin mimetics in ITP and sirolimus for cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). äDiagnosis and Management of Autoimmune Cytopenias in Childhood (epmc).pdf DeepDyve Pubget Overpricing